Bio-Pharma Industry Transformation With Contract Management

By Maria Votlucka on 06/19/19

In early June, CobbleStone exhibited at BIO 2019 in Philadelphia, PA.  There was an abundance of amazing keynotes, super sessions, fireside chats, receptions, and educational sessions ranging from “Biofuels & Renewable Chemicals” to “Value, Patient Access & Reimbursement.”  The sessions on “Business Development & Finance,” “Emerging Opportunities in Global Markets,” and “Intellectual Property” made it clear that biotechnology and pharmaceutical industry leaders from life sciences and academic institutions are eager to face their challenges. Their strategy will beintegrating new technologies into their processes to improve operations, go-to-market efforts, R&D, profitability, and contract performance. 

Continue Reading

Pharmaceutical Contract Management: Sunshine Act Compliance

By George Miller on 12/29/15

The Physician Payments Sunshine Act was passed by the United States in 2010 in an effort to increase the transparency of the fiscal relationships of drug manufacturers, medical device producers, and biological and medical supplies companies with health care providers.  The institution of the Sunshine Act demanded pharmaceutical organizations with relationships to Medicare, Medicaid, and the State Children’s Health Insurance Program (SCHIP) to collect and track data relating to their agreements with entities such as physicians and teaching hospitals. 

Continue Reading
Website Graphics_Collage for Website Module copy
RESERVE MY SEAT
REGISTER TODAY

Lists by Topic

see all